MedPath

The Integrated Support and Palliative in Cancer Day-care Hospital for Patients With Advanced Cancers: Impact on Quality of Life, Care Pathways and Support for Caregivers (HDJ-SPI)

Not Applicable
Active, not recruiting
Conditions
Cancer, Advanced
Interventions
Other: Hospital day care follow-up
Registration Number
NCT04604873
Lead Sponsor
Institut Curie
Brief Summary

The main objective is to show the impact on the quality of life (QoL) for adults patients with advanced cancer managed in day hospital of integrated palliative care of cancer center (HDJ-SPI).

Detailed Description

Not available

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
144
Inclusion Criteria
  1. Patient ≥ 18 years old with advanced solid tumor
  2. Addressed for the first time to the palliative care team according to current criteria (medico-psycho-social symptoms, progressive risks)
  3. With or without anti-cancer treatment
  4. With estimated life expectancy of more than 2 months and less than 12 months
  5. Able to communicate in French and answer questionnaires
  6. Affiliated with a social security system
  7. Having signed informed consent, co-signed by the partner if designated by the patient
Exclusion Criteria
  1. Patient with primitive brain tumor or malignant hemopathy
  2. Severe psychopathological disorders
  3. Pregnant patient or childbearing potential without effective method of birth control
  4. Unable to be followed at the cancer center until death
  5. Patient deprived of liberty or under guardianship -

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Hospital one day careHospital day care follow-upHospital one day care
Primary Outcome Measures
NameTimeMethod
Analyse impact of hospital day care in integrated palliative care department on quality of life of adult patients with advanced stage cancer12 months

Analyse impact of hospital day care in integrated palliative care department on quality of life of adult patients with advanced stage cancer

Outcome shall be evaluated by assessing Survival without quality of life deterioration,measured by EORTC QLQ-C30 scale with monthly evaluation targeting three dimensions :

global quality of life/ fatigue/ patient emotional state

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (6)

Institut de Cancerologie de L'Ouest

🇫🇷

Saint-herblain, France

Institutcurie Paris

🇫🇷

Paris, France

Institut Bergonie

🇫🇷

Bordeaux, France

Centre Antoine Lacassagne

🇫🇷

Nice, France

INSTITUT CURIE Saint-Cloud

🇫🇷

Saint-cloud, France

Centre Paul Strauss

🇫🇷

Strasbourg, France

© Copyright 2025. All Rights Reserved by MedPath